Given the above studies, this study was designed to better understand the molecular mechanism of sevoflurane inhibiting lung cancer progression, and determining relationships among PCAT6, miR-326, and the Wnt/β-catenin pathway. Here, PCAT6 is linked to lung carcinoma.